Dr. Moses is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Novo Nordisk Inc
800 Scudders Mill Road
Plainsboro, NJ 08536Phone+1 609-514-8099
Education & Training
Tufts Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1978 - 1979
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1974 - 1975- Washington University in St. Louis School of MedicineClass of 1973
Certifications & Licensure
MA State Medical License 1979 - 2025
Awards, Honors, & Recognition
- Elected Member The American Society for Clinical Investigation, 1990
Clinical Trials
- Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance Start of enrollment: 1998 Apr 01
Publications & Presentations
PubMed
- 8 citationsDevelopment of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTE.Simon Heller, Ildiko Lingvay, Steven P. Marso, Athena Philis-Tsimikas, Thomas R. Pieber
Diabetes, Obesity & Metabolism. 2020-12-01 - 8 citationsRisk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTESimon Heller, Ildiko Lingvay, Steven P. Marso, Athena Philis-Tsimikas, Thomas R. Pieber
Diabetes, Obesity & Metabolism. 2020-04-06 - 17 citationsRedefining Hypoglycemia in Clinical Trials: Validation of Definitions Recently Adopted by the American Diabetes Association/European Association for the Study of Diabe...Simon Heller, John B. Buse, Robert E. Ratner, Elizabeth R. Seaquist, Lars Bardtrum
Diabetes Care. 2020-02-01
Press Mentions
Virta Health Highlights Lasting, Transformative Health Improvements in 5-Year Diabetes Reversal StudyJune 6th, 2022- BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateMarch 31st, 2021
- BiomX : Appoints Paul Sekhri and Alan Moses, M.D., to Board of DirectorsOctober 5th, 2020
- Join now to see all
Grant Support
- Insulin &Insulin LIKE Growth Factor 1--Insulin ResistanNational Center For Research Resources2000–2002
- Characterization Of Insulin &Insulin LIKE Growth Factor ResponsesNational Center For Research Resources1999–2002
- Inhaled Human Insulin VS Usual Subcutaneous Insulin Therapy In IDDMNational Center For Research Resources1998–2002
- Troglitazone In Moderate To Severe Insulin ResistanceNational Center For Research Resources1997–2002
- Insulin And Insulinlike Growth Factor ResponsesNational Center For Research Resources1996–2002
- Troglitazone With/Without Insulin For Insulin Requiring Patients With NIDDMNational Center For Research Resources1998–1999
- Inhaled Human Insulin VS Usual SQ Human Insulin Therapy In NIDDMNational Center For Research Resources1998–1999
- Biological Effect And Clinical Efficacy Of Octreotide, Analog Of SomatostatinNational Center For Research Resources1996–1999
- Pilot Study Of A Novel, Noninvasive Method Of Blood Glucose MonitoringNational Center For Research Resources1997
- Lyspro VS U-500 Insulin In Treatment Of Antibody Mediated Insulin ResistanceNational Center For Research Resources1997
- General Clinical Research CenterNational Center For Research Resources1996–1997
- Effect Of Lyspro VS U-500 Human Insulin In Treatment Of Antibody Mediated IRNational Center For Research Resources1996
- Dose Finding Study Of RH IGF I In Type II DiabetesNational Center For Research Resources1996
- Mechanism Underlying Local Insulin/Latex AllergyNational Center For Research Resources1995–1996
- Characterization Of Insulin And Insulin-Like Growth Factor I ResponsesNational Center For Research Resources1995–1996
- Recombinant Human IGF-I In The Treatment Of Type II Diabetes MellitusNational Center For Research Resources1995
- Dose Finding Study Of Rhigh I In Type II DiabetesNational Center For Research Resources1995
- Compassionate Use Of Growth Releasing HormoneNational Center For Research Resources1995
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
